Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Brain MRI findings in children and adolescents with Fabry disease.

Marchesoni C, Cisneros E, Pfister P, Yáñez P, Rollan C, Romero C, Kisinovsky I, Rattagan L, León Cejas L, Pardal A, Sevlever G, Reisin R.

J Neurol Sci. 2018 Dec 15;395:131-134. doi: 10.1016/j.jns.2018.10.009. Epub 2018 Oct 5.

PMID:
30316069
2.

Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease.

Carmona S, Weinschelbaum R, Pardal A, Marchesoni C, Zuberbuhler P, Acosta P, Cáceres G, Kisinovsky I, Bayón L, Reisin R.

Audiol Res. 2017 Jul 28;7(2):176. doi: 10.4081/audiores.2017.176. eCollection 2017 Jul 18.

3.

Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology.

Mucci JM, Cuello MF, Kisinovsky I, Larroude M, Delpino MV, Rozenfeld PA.

Blood Cells Mol Dis. 2015 Aug;55(2):134-43. doi: 10.1016/j.bcmd.2015.05.009. Epub 2015 May 27.

PMID:
26142329
4.

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.

Hughes DA, Gonzalez DE, Lukina EA, Mehta A, Kabra M, Elstein D, Kisinovsky I, Giraldo P, Bavdekar A, Hangartner TN, Wang N, Crombez E, Zimran A.

Am J Hematol. 2015 Jul;90(7):584-91. doi: 10.1002/ajh.24012.

5.

Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease.

Cianciulli TF, Saccheri MC, Fernández SP, Fernández CC, Rozenfeld PA, Kisinovsky I.

Echocardiography. 2015 May;32(5):860-3. doi: 10.1111/echo.12900. Epub 2015 Feb 13.

PMID:
25684266
6.

[Guidelines for diagnosis, monitoring and treatment of Fabry disease].

Consenso de Médicos de AADELFA y GADYTEF, Neumann P, Antongiovanni N, Fainboim A, Kisinovsky I, Amartino H, Cabrera G, Carmona S, Ceci R, Cicerán A, Choua M, Doxastakis G, De Maio S, Ebner R, Escobar AM, Ferrari G, Forrester M, Guelbert N, Luna P, Marchesoni C, Masllorens F, Politei J, Reisin R, Ripeau D, Rozenfeld P, Serebrinsky G, Tarabuso AL, Trípoli J.

Medicina (B Aires). 2013;73(5):482-94. Spanish.

7.

Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease.

Saccheri MC, Cianciulli TF, Lax JA, Gagliardi JA, Cáceres GL, Quarin AE, Kisinovsky I, Rozenfeld PA, Reisin RC; AADELFA.

Echocardiography. 2013 Oct;30(9):1069-77. doi: 10.1111/echo.12216. Epub 2013 Apr 19.

PMID:
23600802
8.

Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.

Ben Turkia H, Gonzalez DE, Barton NW, Zimran A, Kabra M, Lukina EA, Giraldo P, Kisinovsky I, Bavdekar A, Ben Dridi MF, Gupta N, Kishnani PS, Sureshkumar EK, Wang N, Crombez E, Bhirangi K, Mehta A.

Am J Hematol. 2013 Mar;88(3):179-84. doi: 10.1002/ajh.23382. Epub 2013 Feb 9. Erratum in: Am J Hematol. 2013 Jul;88(7):632.

9.

Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.

Gonzalez DE, Turkia HB, Lukina EA, Kisinovsky I, Dridi MF, Elstein D, Zahrieh D, Crombez E, Bhirangi K, Barton NW, Zimran A.

Am J Hematol. 2013 Mar;88(3):166-71. doi: 10.1002/ajh.23381. Epub 2013 Feb 6.

10.

Home infusion program for Fabry disease: experience with agalsidase alfa in Argentina.

Kisinovsky I, Cáceres G, Coronel C, Reisin R.

Medicina (B Aires). 2013;73(1):31-4.

11.

Brain MRI findings in patients with Fabry disease.

Reisin RC, Romero C, Marchesoni C, Nápoli G, Kisinovsky I, Cáceres G, Sevlever G.

J Neurol Sci. 2011 Jun 15;305(1-2):41-4. doi: 10.1016/j.jns.2011.03.020. Epub 2011 Apr 3.

PMID:
21463870
12.

Misdiagnosis in Fabry disease.

Marchesoni CL, Roa N, Pardal AM, Neumann P, Cáceres G, Martínez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC.

J Pediatr. 2010 May;156(5):828-31. doi: 10.1016/j.jpeds.2010.02.012.

PMID:
20385321

Supplemental Content

Loading ...
Support Center